About this item:

329 Views | 313 Downloads

Subjects:

Keywords:

  • Anthrax
  • Anti-Bacterial Agents
  • Bacillus anthracis
  • Centers for Disease Control and Prevention (U.S.)
  • Ciprofloxacin
  • Diagnosis, Differential
  • Doxycycline
  • Humans
  • Penicillin G Procaine
  • United States

Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax

Tools:

Journal Title:

Emerging Infectious Disease

Volume:

Volume 8, Number 2

Publisher:

, Pages 222-225

Type of Work:

Article | Final Publisher PDF

Abstract:

On November 18, 2001, a meeting was held at the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, to discuss the prophylaxis, diagnosis, and treatment of anthrax. Participants included clinicians and health department personnel from areas where anthrax cases were identified, infectious disease experts, representatives of professional societies, and experts from federal agencies. A patient recovering from inhalational anthrax also described her illness. The following is a summary of the presentations and discussion.

Copyright information:

Emerging Infectious Diseases is an open access journal published monthly by the Centers for Disease Control and Prevention (CDC).

Export to EndNote